The Download: the mysteries surrounding weight-loss drugs, and the economic effects of AI
This brief outlines recent developments in the realm of weight-loss drugs, particularly the GLP-1 agonists such as Mounjaro and Zepbound, manufactured by Eli Lilly. The company has garnered attention for being the first healthcare firm to reach a trillion-dollar valuation, highlighting the growing significance of these medications. However, recent studies have raised concerns about the […]










